Presentation is loading. Please wait.

Presentation is loading. Please wait.

Management of immune dysfunction after adult cardiac surgery

Similar presentations


Presentation on theme: "Management of immune dysfunction after adult cardiac surgery"— Presentation transcript:

1 Management of immune dysfunction after adult cardiac surgery
J. Scott Rankin, MD, Olusola Oguntolu, MD, Robert S. Binford, MD, D. Scott Trochtenberg, MD, Lawrence H. Muhlbaier, PhD, Charles W. Stratton, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 142, Issue 3, Pages (September 2011) DOI: /j.jtcvs Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Mean ± standard deviation of course of PMI for 3 days before (−3) to 5 days after (+5) beginning IVIgG therapy in 44 postoperative patients. IVIgG therapy was begun on day zero (0). IVIgG was associated with a consistent reversal of worsening of postoperative morbidity and a highly significant treatment effect, using each patient as his/her own control (P < .0001). See text for details. PMI, Postoperative morbidity index; SD, standard deviation; IVIG, intravenous immunoglobulin. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Management of immune dysfunction after adult cardiac surgery"

Similar presentations


Ads by Google